Sirolimus for Alzheimer's risk in women with ApoE4 gene
Treatments studied
Part of Genetic & congenital clinical trials.
This study tests whether sirolimus, a medication that may help the body clear damaged cells, can lower Alzheimer's risk in women with the ApoE4 gene variant. It is an early-stage trial that looks at safety and how the drug affects certain blood markers.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are female and between 45 and 65 years old.
- You carry the ApoE4 gene variant (a common genetic factor that raises Alzheimer's risk).
- You are either post-menopausal or using reliable birth control.
- You are generally independent in daily activities and not diagnosed with dementia or memory problems.
- You do not have major health issues like uncontrolled diabetes, heart problems, or recent stroke.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This Phase 2 trial studies whether sirolimus can slow or prevent functional decline (more difficulty with daily activities) in older adults. You may be considered if you’re in the right age range and have no major heart, lung, liver, kidney, or recent bleeding/clotting problems.
This trial tests an experimental drug called HT-4253 to see if it can prevent Alzheimer's disease in people who are at higher genetic risk (carry the APOE4 gene) and have early signs of amyloid buildup in the brain. If you qualify, you would take the drug or a placebo and be monitored over time.
This study tests whether sirolimus (an immune-calming drug) is safe and helpful for people with antiphospholipid syndrome (APS), a condition that raises the risk of blood clots. If you join, you'll get either sirolimus or a placebo alongside your usual treatment, to see if it reduces clotting problems.
This study tests whether a special diet and supplements can improve body, brain, and longevity in people who carry the APOE e4 gene. It may help slow aging and support memory, but it requires a fairly restrictive health profile.
This study tests a medication called sirolimus to see if it can help older adults stay healthy and independent. The trial is looking for people aged 65 and older who live at home and do not have serious memory problems or major health conditions like kidney or liver disease.
This trial tests whether sirolimus, a medication usually used to prevent organ transplant rejection, can help reduce lupus disease activity. If you have active lupus that isn't severe in your kidneys or brain, this could be a new treatment option.
Hear when a new Genetic Predisposition to Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.